Published in Curr Osteoporos Rep on March 01, 2014
Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol (2017) 0.83
Intermittent applied mechanical loading induces subchondral bone thickening that may be intensified locally by contiguous articular cartilage lesions. Osteoarthritis Cartilage (2015) 0.81
Role of Chondrocytes in Cartilage Formation, Progression of Osteoarthritis and Cartilage Regeneration. J Dev Biol (2015) 0.78
Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol (2016) 0.77
The adipokine lipocalin-2 in the context of the osteoarthritic osteochondral junction. Sci Rep (2016) 0.77
The pro-inflammatory cytokine 14-3-3ε is a ligand of CD13 in cartilage. J Cell Sci (2015) 0.76
Osteoarthritis of the hip joint in elderly patients is most commonly atrophic, with low parameters of acetabular dysplasia and possible involvement of osteoporosis. Arch Osteoporos (2017) 0.75
Ultrashort TE evaluation of the osteochondral junction in vivo: a feasibility study. Br J Radiol (2016) 0.75
MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis. Int J Mol Med (2016) 0.75
The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis. Biol Res (2015) 0.75
Osteoblast role in osteoarthritis pathogenesis. J Cell Physiol (2017) 0.75
Rosmarinic acid induces rabbit articular chondrocyte differentiation by decreases matrix metalloproteinase-13 and inflammation by upregulating cyclooxygenase-2 expression. J Biomed Sci (2017) 0.75
Radiological and histological analysis of two replaced interphalangeal joints with active subchondral bone resorption in erosive hand osteoarthritis: a novel mechanism? Skeletal Radiol (2017) 0.75
The amazing osteocyte. J Bone Miner Res (2011) 5.32
Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med (2003) 4.98
Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum (2006) 2.81
The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum (2004) 2.22
Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum (2008) 2.17
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage (2011) 2.06
Osteoarthritis induction leads to early and temporal subchondral plate porosity in the tibial plateau of mice: an in vivo microfocal computed tomography study. Arthritis Rheum (2011) 1.92
Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage (2011) 1.88
The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis: a longitudinal study. Arthritis Res Ther (2010) 1.83
Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol (2008) 1.68
Increased intracortical remodeling following fatigue damage. Bone (1993) 1.59
Vascular pathology and osteoarthritis. Rheumatology (Oxford) (2007) 1.44
Subchondral bone and cartilage disease: a rediscovered functional unit. Invest Radiol (2000) 1.44
Bone marrow lesions predict site-specific cartilage defect development and volume loss: a prospective study in older adults. Arthritis Res Ther (2010) 1.38
Osteocyte control of osteoclastogenesis. Bone (2012) 1.36
Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep (2013) 1.31
Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther (2009) 1.28
Cartilage loss occurs in the same subregions as subchondral bone attrition: a within-knee subregion-matched approach from the Multicenter Osteoarthritis Study. Arthritis Rheum (2009) 1.28
Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage (2002) 1.25
In situ measurement of transport between subchondral bone and articular cartilage. J Orthop Res (2009) 1.25
Joint immobilization prevents murine osteoarthritis and reveals the highly mechanosensitive nature of protease expression in vivo. Arthritis Rheum (2012) 1.21
The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int (2013) 1.18
Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage (2005) 1.13
The structure of the human subchondral plate. J Bone Joint Surg Br (1990) 1.12
Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int (2012) 1.11
Dkk-1 expression in chondrocytes inhibits experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum (2012) 1.11
Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis. Ann N Y Acad Sci (2007) 1.09
The normal human chondro-osseous junctional region: evidence for contact of uncalcified cartilage with subchondral bone and marrow spaces. BMC Musculoskelet Disord (2006) 1.07
Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis. Arthritis Rheum (2008) 1.07
Osteophytes and the osteoarthritic femoral head. J Bone Joint Surg Br (1975) 1.06
Material properties of bone from the femoral neck and calcar femorale of patients with osteoporosis or osteoarthritis. Osteoporos Int (1997) 1.03
Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum (2009) 1.00
Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution. Bone (2002) 0.98
Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum (1999) 0.98
Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. PLoS One (2012) 0.98
Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res (2004) 0.95
Application of in vivo micro-computed tomography in the temporal characterisation of subchondral bone architecture in a rat model of low-dose monosodium iodoacetate-induced osteoarthritis. Arthritis Res Ther (2011) 0.95
Femoral trabecular bone of osteoarthritic and normal subjects in an age and sex matched group. Osteoarthritis Cartilage (1998) 0.92
Difference in subchondral cancellous bone between postmenopausal women with hip osteoarthritis and osteoporotic fracture: implication for fatigue microdamage, bone microarchitecture, and biomechanical properties. Arthritis Rheum (2012) 0.88
Hypoxia and HIF-1alpha expression in the epiphyseal cartilage following ischemic injury to the immature femoral head. Bone (2009) 0.88
The effect of cyclic deformation and solute binding on solute transport in cartilage. Arch Biochem Biophys (2006) 0.87
Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis. Osteoarthritis Cartilage (2013) 0.86
Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. J Bone Miner Res (2011) 0.86
Quantifying load-induced solute transport and solute-matrix interaction within the osteocyte lacunar-canalicular system. J Bone Miner Res (2013) 0.85
Critical molecular regulators, histomorphometric indices and their correlations in the trabecular bone in primary hip osteoarthritis. Osteoarthritis Cartilage (2010) 0.85
Chondrocyte survival in articular cartilage: the influence of subchondral bone in a bovine model. J Bone Joint Surg Br (2009) 0.84
Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients. Arthritis Res Ther (2006) 0.84
Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis. Climacteric (2010) 0.84
In vivo bone-specific EphB4 overexpression in mice protects both subchondral bone and cartilage during osteoarthritis. Arthritis Rheum (2012) 0.84
The bone marrow lesion in osteoarthritis. Rheumatol Int (2010) 0.83
Reduced tissue hardness of trabecular bone is associated with severe osteoarthritis. J Biomech (2011) 0.81
Specific inhibitory protein Dkk-1 blocking Wnt/β-catenin signaling pathway improve protectives effect on the extracellular matrix. J Huazhong Univ Sci Technolog Med Sci (2011) 0.81
An update on primary hip osteoarthritis including altered Wnt and TGF-β associated gene expression from the bony component of the disease. Rheumatology (Oxford) (2011) 0.81
Shock absorbing ability of articular cartilage and subchondral bone under impact compression. J Mech Behav Biomed Mater (2013) 0.78
Evidence for the dysregulated expression of TWIST1, TGFβ1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients. Osteoarthritis Cartilage (2012) 0.78
Bone marrow lesions in the knee: the clinical conundrum. Int J Rheum Dis (2010) 0.77
Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Res (2003) 2.73
Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. J Bone Miner Res (2013) 2.25
Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res (2008) 2.11
Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One (2011) 2.10
TWEAK is a novel arthritogenic mediator. J Immunol (2006) 1.37
Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res (2009) 1.36
Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol (2005) 1.26
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Int J Cancer (2002) 1.11
The proliferation and phenotypic expression of human osteoblasts on tantalum metal. Biomaterials (2004) 1.07
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone (2004) 1.06
Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology (2010) 1.04
Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomater (2011) 1.02
The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med (2008) 0.99
Primary human osteoblasts grow into porous tantalum and maintain an osteoblastic phenotype. J Biomed Mater Res A (2008) 0.97
Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone (2004) 0.97
Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. J Neuroinflammation (2013) 0.96
The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. Biomaterials (2006) 0.93
The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. J Bone Miner Metab (2008) 0.93
Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma. Clin Cancer Res (2009) 0.93
Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J Bone Miner Res (2008) 0.92
Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. J Bone Miner Res (2004) 0.87
TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Arthritis Res Ther (2011) 0.86
Vitamin D metabolism within bone cells: effects on bone structure and strength. Mol Cell Endocrinol (2011) 0.86
Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells. J Steroid Biochem Mol Biol (2012) 0.84
A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway. J Signal Transduct (2012) 0.84
Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management. Inflammopharmacology (2013) 0.83
SaOS2 Osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes. Calcif Tissue Int (2014) 0.83
The pleiotropic effects of vitamin D in bone. J Steroid Biochem Mol Biol (2012) 0.83
Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts. Curr Drug Targets (2013) 0.81
An update on primary hip osteoarthritis including altered Wnt and TGF-β associated gene expression from the bony component of the disease. Rheumatology (Oxford) (2011) 0.81
Characterization of drug-release kinetics in trabecular bone from titania nanotube implants. Int J Nanomedicine (2012) 0.79
TWEAK and TNF regulation of sclerostin: a novel pathway for the regulation of bone remodelling. Adv Exp Med Biol (2011) 0.79
The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation. J Biol Chem (2013) 0.79
Biomimetic hydroxyapatite coating on glass coverslips for the assay of osteoclast activity in vitro. J Mater Sci Mater Med (2009) 0.79
Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. Mol Cell Endocrinol (2013) 0.79
Circulating levels of TWEAK correlate with bone erosion in multiple myeloma patients. Br J Haematol (2010) 0.78
Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis? Blood (2008) 0.76
An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors. Methods Mol Med (2005) 0.75